Corteva Inc

Aktienanalyse zu Corteva Inc (CTVA)

$12.880

0.000 (0.00%)Zum Schluss

Loading chart…
Hoch
13.170
Eröffnung
12.988
Volumengewichteter Durchschnittskurs
12.91
Volumen
15.71M
Marktkap.
37.39B
Tief
12.690
Umsatz
202.90M
EV/EBITDA, TTM
4.81

Corteva, Inc. is a global pure-play agriculture company that combines customer engagement and operational execution to deliver solutions. The Company generates advantaged market preference through its distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. It serves the global agricultural input industry with crop protection solutions that improve farmer productivity and profitability by protecting against weeds, insects and other pests, and disease, and by supporting overall crop health both above and below ground via nitrogen management and seed applied technologies. The Company's offerings includes herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products.

www.corteva.com

KI-Analyse of Corteva Inc (CTVA)

Verkaufen

Corteva is not a good buy right now due to a current price of $12.88, which is significantly below analyst targets, and a concerning RSI of 7.338 indicating oversold conditions. The stock has also experienced a drastic 80.99% decline year-to-date, suggesting a lack of investor confidence and potential ongoing volatility.

Bewertungskennzahlen

Das aktuelle erwartete KGV von Corteva Inc (CTVA) beträgt 19.08, verglichen mit dem 5-Jahres-Durchschnitt von 20.35.

Erwartetes KGV

Fair bewertet
5J-Durchschnitt P/E
20.35
Aktuelles P/E
19.08
Überbewertet
22.41
Unterbewertet
18.28

Erwartetes EV/EBITDA

Stark unterbewertet
5J-Durchschnitt EV/EBITDA
12.03
Aktuelles EV/EBITDA
4.81
Überbewertet
14.36
Unterbewertet
9.71

Erwartetes KUV

Stark unterbewertet
5J-Durchschnitt P/S
2.37
Aktuelles P/S
1.03
Überbewertet
2.71
Unterbewertet
2.04

Alphio-AI-Kursszenarien für CTVA

Szenariopreise sind das letzte monatliche Prognoseband des laufenden Jahres. Die Wahrscheinlichkeiten sind feste Modellgewichte (25 / 50 / 25), keine Garantien.

B

Bullisch

Bullisch · 25%CTVA

$82.20

Szenariopreis

B

Basis

Basis · 50%CTVA

$67.79

Szenariopreis

B

Bärisch

Bärisch · 25%CTVA

$54.24

Szenariopreis

Whales, die CTVA halten

S

Staley Capital Advisers, Inc.

+ HältCTVA

+2.00%

3-Monats-Rendite

C

Clifford Swan Investment Counsel LLC

+ HältCTVA

+1.37%

3-Monats-Rendite

D

Dearborn Partners L.L.C.

+ HältCTVA

+0.32%

3-Monats-Rendite

Z

ZWJ Investment Counsel Inc

+ HältCTVA

+0.03%

3-Monats-Rendite

A

Aristotle Capital Management, LLC

+ HältCTVA

-1.51%

3-Monats-Rendite

R

Rokos Capital Management LLP

+ HältCTVA

-2.00%

3-Monats-Rendite

Event-Zeitleiste

2026-10-15 (ET)

10:30:00

RBC Cuts FMC Q3 EBITDA Guidance to $538M

2026-10-06 (ET)

16:30:00

McKesson and CD&R Agree to Acquire Option Care Health for $32.05 per Share

12:00:00

Major Averages Rise for Second Day Amid Treasury Yield Retreat

10:00:00

Constellation Energy Gains $41.50 to $309.12

09:00:00

Stock Futures Rise as Oil Prices Ease

News

CTVA FAQ – beantwortet von Alphio AI

Corteva, Inc. is a global pure-play agriculture company that combines customer engagement and operational execution to deliver solutions. The Company generates advantaged market preference through its distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. It serves the global agricultural input industry with crop protection solutions that improve farmer productivity and profitability by protecting against weeds, insects and other pests, and disease, and by supporting overall crop health both above and below ground via nitrogen management and seed applied technologies. The Company's offerings includes herbicides, insecticides, nitrogen stabilizers, pasture and range management herbicides and biologicals and other nature-based products. It operates in the Basic Materials sector.

Corteva is not a good buy right now due to a current price of $12.88, which is significantly below analyst targets, and a concerning RSI of 7.338 indicating oversold conditions. The stock has also experienced a drastic 80.99% decline year-to-date, suggesting a lack of investor confidence and potential ongoing volatility.

Community

Mehr ↗

Noch keine Beiträge

Registriere dich oder melde dich an, um mitzudiskutieren

Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.

Jetzt handeln